Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,893,271
+$10,658,784 QoQ
Shares Held
1,420,244
+1099.2% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$182,546
PutShares
23,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,565,450,068 across 341 Biotechnology names. IBRX ranks #102 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in IBRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $182,546 | 23,800 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $10,893,271 | 1,420,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $234,487 | 118,428 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $118,808 | 48,296 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,563,383 | 3,243,706 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,293,556 | 429,753 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $599,239 | 234,078 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,154,365 | 1,116,765 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $591,495 | 93,591 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $291,854 | 54,349 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $537,000 | 100,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $1,879,500 | 350,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $302,746 | 60,308 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $74,632 | 44,161 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $947,912 | 520,831 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,984,376 | 399,271 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,388,800 | 1,179,785 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,422,599 | 610,089 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,686,002 | 277,303 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $636,343 | 65,333 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $908,879 | 63,647 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,764,879 | 74,342 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $2,374,000 | 100,000 | Call | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||